These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15290423)

  • 1. Anesthetic management of a patient undergoing cardioverter defibrillator implantation: usefulness of transesophageal echocardiography and near infrared spectroscopy.
    Jinnouchi Y; Kawahito S; Kitahata H; Tanaka K; Nozaki J; Oshita S
    J Anesth; 2004; 18(3):220-3. PubMed ID: 15290423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anesthetic management for AICD (automatic implantable cardioverter defibrillator) implant surgery].
    Ohnishi Y; Kikumoto K; Hayami H; Kuro M
    Masui; 1996 Feb; 45(2):239-43. PubMed ID: 8865716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral oxygenation during defibrillator threshold testing of implantable cardioverter defibrillators.
    McNeill E; Gagnon RE; Potts JE; Yeung-Lai-Wah JA; Kerr CR; Sanatani S
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):528-33. PubMed ID: 15955185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anesthetic management for implantation of implantable cardioverter-defibrillators].
    Hara M; Uchida O; Kuro M; Kurita T
    Masui; 1999 Jul; 48(7):747-52. PubMed ID: 10434515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators.
    Dworschak M; Franz M; Czerny M; Gorlitzer M; Blaschek M; Grubhofer G; Haider W
    Crit Care Med; 2003 Aug; 31(8):2085-9. PubMed ID: 12973163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Failure in the functioning of an implanted automatic defibrillator due to pneumothorax occurring during its implantation ].
    Navarro-Martínez J; Barrera E; Trillo L; Martí J; Delclós J; Escolano F
    Rev Esp Anestesiol Reanim; 2002 May; 49(5):268-71. PubMed ID: 12216510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anesthetic management for cardioverter defibrillator implantation in a patient with preoperatively undiagnosed myotonic dystrophy].
    Asada M; Suzuki H; Sumitomo M
    Masui; 2001 Oct; 50(10):1136-8. PubMed ID: 11712353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].
    Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F
    Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [RF ablation in a patient with recurrent post-infarction ventricular tachycardia requiring multiple cardioverter-defibrillator interventions].
    Kuśnierz J; Szumowski L; Pastwa L; Bardyszewski A; Lech B; Gil R; Walczak F
    Kardiol Pol; 2005 Nov; 63(5):563-8. PubMed ID: 16362864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anesthetic management of cardiac tamponade after dual-chamber implantable cardioverter defibrillator implantation in a patient with dilated cardiomyopathy.
    Sato Y; Horiguchi T; Nishikawa T
    J Clin Anesth; 2004 Nov; 16(7):554-6. PubMed ID: 15590264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.